Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9695832 | 0.93 | AGTR1 (0.62) | AGTR1 | |
| SCHEMBL9309106 | 0.92 | AGTR1 (0.77) | AGTR1AGTR2 | |
| SCHEMBL9695758 | 0.91 | AGTR1 (0.54) | AGTR1AGTR2 | |
| SCHEMBL7299689 | 0.88 | AGTR1 (0.69) | AGTR1AGTR2 | |
| SCHEMBL9694882 | 0.87 | AGTR1 (0.58) | AGTR1 | |
| SCHEMBL9694857 | 0.87 | AGTR1 (0.67) | AGTR1AGTR2 | |
| SCHEMBL9310803 | 0.87 | AGTR1 (0.72) | AGTR1AGTR2 | |
| SCHEMBL9310972 | 0.86 | AGTR1 (0.69) | AGTR1AGTR2 | |
| SCHEMBL7310828 | 0.85 | AGTR1 (0.63) | AGTR1AGTR2 | |
| SCHEMBL9309977 | 0.85 | AGTR1 (0.71) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992016552-A1 | 1-IMIDAZOLGEMETHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF ANGIOTENSIN II ACTIVITY | GLAXO GROUP LIMITED (GB) | 1992-10-01 | — | — | WO | claimed |
| EP-0505954-A1 | N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity | GLAXO GROUP LIMITED (GB) | 1992-09-30 | — | — | EP | claimed |
| WO-1992016552-A1 | 1-IMIDAZOLGEMETHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF ANGIOTENSIN II ACTIVITY | GLAXO GROUP LIMITED (GB) | 1992-10-01 | — | — | WO | disclosed |
| EP-0505954-A1 | N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity | GLAXO GROUP LIMITED (GB) | 1992-09-30 | — | — | EP | disclosed |